Your email address will be used for Wildy’s marketing materials only. We will never give your email address to any third party. You may opt out at any time by following the unsubscribe link included in every email.
Special Discounts for Newly Called & Students
Browse Secondhand Online
Wildy's will be closed on Monday 28th May, re-opening on Tuesday 29th.
Online book orders received during the time we are closed will be processed as soon as possible once we re-open on Tuesday.
As usual credit cards will not be charged until the order is processed and ready to despatch.
Any Sweet & Maxwell or Lexis eBook orders placed after 4pm on the Friday 25th May will not be processed until Tuesday May 29th. UK orders for other publishers will be processed as normal. All non-UK eBook orders will be processed on Tuesday May 29th.
Protection of Intellectual Property Rights (IPRs) has become a global issue. The Trade-Related Aspects of Intellectual Property (TRIPS) Agreement outlines the minimum standards for IPR protection for WTO members and offers a global regime for IPR protection.
However, the social costs of this regime often outweigh the benefits of IPR protection, particularly in the poorest countries, where resources for R&D and social protection are inadequate, but the cost of innovation high. Today, after more than a decade of intense debate over global IPR protection, the problems remain acute, despite limited evidence of co-operation and partnership, most notably in patent pooling and pricing in respect of AIDS drugs.
This book examines various views of the role of IPRs as incentives for innovation against the backdrop of development and the transfer of technology between globalised, knowledge-based, high technology economies. The book retraces the origins, content and interpretations of the TRIPS Agreement, including by WTO dispute settlement organs. It also analyses sources of controversy over IPRs, examining pharmaceutical industry strategies of emerging countries with different IPR policies.
The book also draws attention to the fact that TRIPS is only an agreement about principles; both the TRIPS rules and international customary rules of interpretation are flexible and a great deal depends on domestic policy objectives and their implementation. The author concludes that for governments in developing countries, as well as for their business and scientific communities, IPR protection should be supporting domestic policies for innovation and investment.
This, in turn requires re-casting the debate about TRIPS to place co-operation in global and efficient R&D at the heart of concerns over IPR protection.